Related Experiment Video
Updated: Jan 27, 2026

Contrast Ultrasound Targeted Treatment of Gliomas in Mice via Drug-Bearing Nanoparticle Delivery and Microvascular Ablation
Published on: December 15, 2010
Causative glaucoma treatment: promising targets and delivery systems
Raphael Mietzner1, Miriam Breunig1
1Department of Pharmaceutical Technology, University Regensburg, Universitaetsstrasse 31, 93040 Regensburg, Germany.
This study explores key molecular mediators like TGF-β2 and CTGF in elevated intraocular pressure (IOP) and glaucoma. It highlights novel drug delivery strategies for more effective, causative glaucoma treatments.
Area of Science:
- Ophthalmology
- Molecular Biology
- Pharmacology
Background:
- Glaucoma is a leading cause of global blindness.
- Elevated intraocular pressure (IOP) is a primary modifiable risk factor for glaucoma.
- Current glaucoma therapies face challenges with compliance, bioavailability, and lack of causative treatment.
Purpose of the Study:
- To identify key molecular mediators involved in pathological changes associated with elevated IOP.
- To discuss the roles of transforming growth factor-β2 (TGF-β2), connective tissue growth factor (CTGF), integrins, Rho-associated kinase (ROCK), and nitric oxide (NO) in glaucoma pathogenesis.
- To highlight novel drug delivery approaches for causative glaucoma treatment.
Main Methods:
- Literature review and discussion of molecular mechanisms.
- Analysis of the involvement of specific signaling pathways and molecules in ocular hypertension.
- Exploration of advanced drug delivery systems for ocular conditions.
Main Results:
- TGF-β2, CTGF, integrins, ROCK, and NO are identified as crucial mediators in glaucoma development.
- These molecules play significant roles in the structural and functional changes associated with elevated IOP.
- New drug delivery strategies offer potential for improved therapeutic outcomes.
Conclusions:
- Understanding the molecular basis of glaucoma is essential for developing targeted therapies.
- Intervention at the molecular level, utilizing novel drug delivery, holds promise for treating the cause of glaucoma.
- Further research into these mediators and delivery systems can advance glaucoma management.
Related Concept Videos
Open Angle Glaucoma: Treatment
Drugs such as carbonic anhydrase inhibitors, α2- and...
Angle Closure Glaucoma: Treatment
Correlation and Causation
Correlation versus Causation
If the dependent variable increases or decreases when the independent variable increases, there is a positive or negative...
Glaucoma: Overview
Second Order systems II
First Order Systems
When a first-order system is subjected to a unit-step input, its response is characterized by its transfer function. By applying the Laplace transform of the unit-step input to the transfer function, expanding the...

